Literature DB >> 12823707

Immunohistochemistry in the diagnosis of soft tissue tumours.

J M Coindre1.   

Abstract

Immunohistochemistry is particularly important in the field of soft tissue tumours because of their variety and the frequent difficulty of diagnosis. The first part of this paper discusses useful or new antibodies, together with others that are no longer of use. The second part is devoted to the role of immunohistochemistry in the diagnosis of soft tissue tumours: identification of some rare or atypical benign lesions, identification of non-mesenchymal malignant tumours, and classification of sarcomas. The respective roles of immunohistochemistry and molecular biology are underlined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823707     DOI: 10.1046/j.1365-2559.2003.01639.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  21 in total

1.  The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice.

Authors:  X Hao; T N Fredrickson; S K Chattopadhyay; W Han; C-F Qi; Z Wang; J M Ward; J W Hartley; H C Morse
Journal:  Vet Pathol       Date:  2010-05       Impact factor: 2.221

Review 2.  Nanostructure-initiator mass spectrometry metabolite analysis and imaging.

Authors:  Matthew P Greving; Gary J Patti; Gary Siuzdak
Journal:  Anal Chem       Date:  2010-11-04       Impact factor: 6.986

3.  Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes.

Authors:  Justin A Bishop; Elizabeth A Montgomery; William H Westra
Journal:  Am J Surg Pathol       Date:  2014-02       Impact factor: 6.394

4.  Proceedings of the 2016 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Vivian S Chen; Schantel Hayes-Bouknight; Jessica S Hoane; Kyathanahalli Janardhan; Linda H Kooistra; Thomas Nolte; Kathleen A Szabo; Gabrielle A Willson; Jeffrey C Wolf; David E Malarkey
Journal:  Toxicol Pathol       Date:  2016-11-11       Impact factor: 1.902

5.  Immunohistochemical Characterization of Sarcomas in Trp53+/- Haploinsufficient Mice.

Authors:  M P Jokinen; D L Morgan; H C Price; R A Herbert; T Saddler; D Dixon
Journal:  Toxicol Pathol       Date:  2017-08       Impact factor: 1.902

6.  Primary epithelioid angiosarcoma of the male breast: report of a case.

Authors:  Ze-Sheng Wang; Na Zhan; Cheng-Long Xiong; Hui Li
Journal:  Surg Today       Date:  2007-08-27       Impact factor: 2.549

7.  Immunohistochemistry as an important tool in biomarkers detection and clinical practice.

Authors:  Leandro Luongo de Matos; Damila Cristina Trufelli; Maria Graciela Luongo de Matos; Maria Aparecida da Silva Pinhal
Journal:  Biomark Insights       Date:  2010-02-09

8.  Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.

Authors:  Antoine Lurkin; Francoise Ducimetière; Dominique Ranchère Vince; Anne-Valérie Decouvelaere; Dominic Cellier; François N Gilly; Dimitri Salameire; Pierre Biron; Guy de Laroche; Jean Yves Blay; Isabelle Ray-Coquard
Journal:  BMC Cancer       Date:  2010-04-19       Impact factor: 4.430

9.  Histopathology of hemangiosarcomas in mice and hamsters and liposarcomas/fibrosarcomas in rats associated with PPAR agonists.

Authors:  Jerry F Hardisty; Michael R Elwell; Heinrich Ernst; Peter Greaves; Holly Kolenda-Roberts; David E Malarkey; Peter C Mann; Pierre A Tellier
Journal:  Toxicol Pathol       Date:  2007-12       Impact factor: 1.902

10.  PIM-1 kinase expression in adipocytic neoplasms: diagnostic and biological implications.

Authors:  Min En Nga; Nu Nu Ma Swe; Kang Ting Chen; Liang Shen; Michael B Lilly; Siew Pang Chan; Manuel Salto-Tellez; Kakoli Das
Journal:  Int J Exp Pathol       Date:  2009-10-28       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.